PAVmed Inc. Amortization of Intangible Assets
PAVmed Inc. (PAVM) reported Amortization of Intangible Assets of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-03-27
- PAVmed Inc. amortization of intangible assets for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- PAVmed Inc. amortization of intangible assets for the quarter ending 2024-09-30 was $82.00K, a 83.76% decline year-over-year.
- PAVmed Inc. amortization of intangible assets for the quarter ending 2024-06-30 was $105.00K, a 79.21% decline year-over-year.
- PAVmed Inc. amortization of intangible assets for the quarter ending 2024-03-31 was $372.00K, a 26.34% decline year-over-year.
- PAVmed Inc. amortization of intangible assets for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- PAVmed Inc. amortization of intangible assets for fiscal 2024 was $559.00K, a 72.34% decline from fiscal 2023.
- PAVmed Inc. amortization of intangible assets for fiscal 2023 was $2.02M, a 13.28% increase from fiscal 2022.
- PAVmed Inc. amortization of intangible assets for fiscal 2022 was $1.78M, a 1121.92% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-27 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $82.00K derived: sum of 2 quarters · filed 2026-03-27 | $187.00K derived: sum of 3 quarters · filed 2026-03-27 | $559.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $82.00K 10-Q · filed 2025-11-12 | $187.00K derived: sum of 2 quarters · filed 2025-11-12 | $559.00K 10-Q · filed 2025-11-12 | $1.06M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $105.00K 10-Q · filed 2025-08-14 | $477.00K 10-Q · filed 2025-08-14 | $982.00K derived: sum of 3 quarters · filed 2025-08-14 | $1.49M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $372.00K 10-Q · filed 2025-05-15 | $877.00K derived: sum of 2 quarters · filed 2025-05-15 | $1.38M derived: sum of 3 quarters · filed 2025-05-15 | $1.89M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $505.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $1.01M derived: sum of 2 quarters · filed 2025-03-24 | $1.51M derived: sum of 3 quarters · filed 2025-03-24 | $2.02M 10-K · filed 2025-03-24 |
| 2023-09-30 | $505.00K 10-Q · filed 2024-11-14 | $1.01M derived: sum of 2 quarters · filed 2024-11-14 | $1.52M 10-Q · filed 2024-11-14 | $2.02M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $505.00K 10-Q · filed 2024-08-12 | $1.01M 10-Q · filed 2024-08-12 | $1.52M derived: sum of 3 quarters · filed 2024-08-12 | $2.02M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $505.00K 10-Q · filed 2024-05-13 | $1.01M derived: sum of 2 quarters · filed 2024-05-13 | $1.52M derived: sum of 3 quarters · filed 2024-05-13 | $2.17M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $506.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $1.01M derived: sum of 2 quarters · filed 2024-03-25 | $1.66M derived: sum of 3 quarters · filed 2024-03-25 | $1.78M 10-K · filed 2024-03-25 |
| 2022-09-30 | $505.00K 10-Q · filed 2023-11-13 | $1.16M derived: sum of 2 quarters · filed 2023-11-13 | $1.28M 10-Q · filed 2023-11-13 | $1.40M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $650.00K 10-Q · filed 2023-08-14 | $773.00K 10-Q · filed 2023-08-14 | $896.00K derived: sum of 3 quarters · filed 2023-08-14 | $913.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $123.00K 10-Q · filed 2023-05-15 | $246.00K derived: sum of 2 quarters · filed 2023-05-15 | $263.00K derived: sum of 3 quarters · filed 2023-05-15 | $269.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $140.00K derived: sum of 2 quarters · filed 2023-03-14 | $146.00K derived: sum of 3 quarters · filed 2023-03-14 | $146.00K 10-K · filed 2023-03-14 |
| 2021-09-30 | $17.00K 10-Q · filed 2022-11-14 | $23.00K derived: sum of 2 quarters · filed 2022-11-14 | $23.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $6.00K 10-Q · filed 2022-08-15 | $6.00K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InspireMD, Inc. (NSPR) | $0.033B | ||
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |